DVAX vs PAYC · rev $277.2M vs P/E 33, rev $1.10B
Dynavax Technologies Corporation (DVAX) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Latest reported PAYC revenue for 2026-06-30 was $1.10B. Net income was $263.1M. Revenue was up 92.9% from 2026-03-31 to 2026-06-30. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
DVAX currently screens at market cap $1.82B. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the DVAX and PAYC stock pages for the full models.
Not investment advice.